Circulating tumor DNA as a marker of residual tumor in colon cancer

Circulating tumor DNA as a marker of residual tumor in colon cancer

Colon cancer is the 3rd most common malignant neoplasm and the 4th leading cause of mortality from them. The majority of patients are diagnosed at stages II–IV, which indicates the need for markers that can predict disease progression, especially after surgical treatment. Recently, there has been a...

Bibliografske podrobnosti
Main Authors:	M. Yu. Fedyanin, Kh. Kh.-M. Elsnukaeva, V. A. Aliev, T. S. Ayrapetyan, A. V. Polyakov, E. V. Moroz, V. A. Uymanov, U. A. Boyarskikh, A. A. Kechin, M. L. Filipenko, S. А. Tjulandin
Format:	Article
Jezik:	Russian
Izdano:	“ABV-press” Publishing house”, LLC 2018-11-01
Serija:	Тазовая хирургия и онкология
Teme:	colon cancer circulating tumor dna liquid biopsy prognosis
Online dostop:	https://ok.abvpress.ru/jour/article/view/255

Podobne knjige/članki

Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer
od: E. M. Polyanskaya, et al.
Izdano: (2022-04-01)

The role of circulating tumor DNA in patients with colon cancer
od: M. Yu. Fedyanin, et al.
Izdano: (2016-10-01)

Localization of the primary tumor of the colon: аre there essential differences?
od: M. Yu. Fedyanin, et al.
Izdano: (2017-12-01)

The prognostic value of circulating in blood tumor DNA as a marker of minimal residual disease in stage I–III colorectal cancer
od: E. M. Polyanskaya, et al.
Izdano: (2022-06-01)

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
od: Emne Ali Abdallah, et al.
Izdano: (2021-01-01)

Some aspects of immunotherapy in colon cancer
od: M. Yu. Fedyanin, et al.
Izdano: (2018-05-01)

Chemotherapy of metastatic colon cancer
od: M. Yu. Fedyanin, et al.
Izdano: (2015-02-01)

FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study
od: M. Yu. Fedyanin, et al.
Izdano: (2019-11-01)

Cell-free circulating tumor DNA in cancer
od: Zhen Qin, et al.
Izdano: (2016-04-01)

Role of microsatellite instability in colon cancer
od: M. Yu. Fedyanin, et al.
Izdano: (2015-02-01)

Comprehensive characterization of circulating tumor cells and cell‐free DNA in patients with metastatic melanoma
od: Manouk K. Bos, et al.
Izdano: (2024-11-01)

FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER
od: M. Yu. Fedyanin, et al.
Izdano: (2015-02-01)

Circulating tumor DNA detection (liquid biopsy): prospects in oncology
od: N. V. Zhukov, et al.
Izdano: (2015-01-01)

Circulating tumor DNA detection (liquid biopsy): prospects in oncology
od: N. V. Zhukov, et al.
Izdano: (2015-01-01)

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
od: Wei Zhang, et al.
Izdano: (2017-02-01)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
od: Jie Li, et al.
Izdano: (2018-09-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
od: Qianwei Ye, et al.
Izdano: (2019-07-01)

CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY
od: M. Yu. Fedyanin, et al.
Izdano: (2015-05-01)

Colon metastasis from malignant müllerian tumor of uterine cervix: A case report
od: Zhenjun Li, et al.
Izdano: (2024-03-01)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
od: Jee‐Soo Lee, et al.
Izdano: (2019-08-01)

Circulating Tumor Cells for Glioma
od: Huikai Zhang, et al.
Izdano: (2021-03-01)

Current Methods of Circulating Tumor Cell Detection
od: Minji Lim, et al.
Izdano: (2018-09-01)

Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer
od: PAN Ruixin, CHEN Xiaosong, SHEN Kunwei
Izdano: (2022-09-01)

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring
od: Ga Young Moon, et al.
Izdano: (2025-01-01)

Detection of circulating tumor cells and the importance of their measurement in urological cancers
od: Michio Naoe, et al.
Izdano: (2018-01-01)

Overall survival in colon cancer patients with different levels of circulating tumor cells and feasibility of enhancing its prognostic value
od: O. I. Kit, et al.
Izdano: (2022-09-01)

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
od: S. J. Schraa, et al.
Izdano: (2020-08-01)

Clinical Application of Circulating Tumor Cells in Gastric Cancer
od: Moon Won Lee, et al.
Izdano: (2019-02-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
od: Xianliang Cheng, et al.
Izdano: (2017-11-01)

Insights into brain metastasis: Recent advances in circulating tumor cell research
od: Remi Klotz, et al.
Izdano: (2022-04-01)

HARDWARE-CONTROLLED INTRA- AND POSTOPERATIVE DECOMPRESSION AND LAVAGE OF THE COLON IN SURGICAL TREATMENT OF TUMOR OBSTRUCTION
od: S. A. Aliev, et al.
Izdano: (2016-02-01)

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
od: François-Clément Bidard, et al.
Izdano: (2019-05-01)

Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
od: Lingyu Li, et al.
Izdano: (2024-11-01)

The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
od: Theresa D. Ahrens, et al.
Izdano: (2020-08-01)

PROPERTIES OF SURGICAL TACTICS IN TREATMENT OF TUMOROUS COLONIC OBSTRUCTION
od: Y. M. Stoyko, et al.
Izdano: (2015-12-01)

Clinical applications and perspectives of circulating tumor DNA in gastric cancer
od: Jing-Han Li, et al.
Izdano: (2024-01-01)

Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer
od: YANG Xiaoying, et al.
Izdano: (2021-09-01)

Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
od: Laure Cayrefourcq, et al.
Izdano: (2021-02-01)

Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
od: Katerina Vlataki, et al.
Izdano: (2023-06-01)

POSTOPERATIVE INTRAABDOMINAL COMPLICATIONS IN COLON CANCER SURGERY COMPLICATED BY BOWEL OBSTRUCTION AND PERFORATION OF THE TUMOR
od: S. A. Aliev, et al.
Izdano: (2015-10-01)